Equifax (EFX) versus Everyday Health (EVDY) Head-To-Head Survey
Equifax (NYSE: EFX) and Everyday Health (NYSE:EVDY) are both business services companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.
Earnings & Valuation
This table compares Equifax and Everyday Health’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Equifax||$3.29 billion||3.88||$1.22 billion||$4.72||22.46|
Equifax has higher revenue and earnings than Everyday Health. Everyday Health is trading at a lower price-to-earnings ratio than Equifax, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
90.0% of Equifax shares are held by institutional investors. Comparatively, 73.1% of Everyday Health shares are held by institutional investors. 1.3% of Equifax shares are held by insiders. Comparatively, 19.8% of Everyday Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Equifax pays an annual dividend of $1.56 per share and has a dividend yield of 1.5%. Everyday Health does not pay a dividend. Equifax pays out 33.1% of its earnings in the form of a dividend. Everyday Health has increased its dividend for 5 consecutive years.
This is a summary of recent ratings and recommmendations for Equifax and Everyday Health, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Equifax currently has a consensus target price of $130.27, suggesting a potential upside of 22.90%. Everyday Health has a consensus target price of $10.63, suggesting a potential upside of 1.19%. Given Equifax’s stronger consensus rating and higher probable upside, equities analysts clearly believe Equifax is more favorable than Everyday Health.
This table compares Equifax and Everyday Health’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Risk & Volatility
Equifax has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500. Comparatively, Everyday Health has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500.
Equifax beats Everyday Health on 10 of the 14 factors compared between the two stocks.
Equifax Inc. is a global provider of information solutions and human resources business process outsourcing services for businesses, governments and consumers. The Company operates in four segments: U.S. Information Solutions (USIS), International, Workforce Solutions and Global Consumer Solutions. Its products and services are based on databases of consumer and business information derived from various sources, including credit, financial assets, telecommunications and utility payments, employment, income, demographic and marketing data. It uses statistical techniques and software tools to analyze all available data, creating customized insights, decision-making solutions and processing services for its clients. It helps consumers understand, manage and protect their personal information and make more informed financial decisions. The Company also provides information, technology and services to support debt collections and recovery management.
About Everyday Health
Everyday Health, Inc., formerly Waterfront Media Inc., operates a digital marketing and communications platform for healthcare marketers that want to engage with consumers and healthcare professionals. The Company’s platform combines content from brands, data and analytics. The Company’s segment is providing digital health marketing and communications solutions. The Company’s flagship brand, Everyday Health, is a health information portal that provides consumers with actionable health information intended to empower users to manage their health and wellness. The Company’s flagship professional property, MedPage Today, includes a team of approximately 30 journalists, including editors, reporters and videographers, and provides clinical news based on research findings published in peer-reviewed medical journals, as well as research reported at various medical conferences around the world.
Receive News & Stock Ratings for Equifax Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax Inc. and related stocks with our FREE daily email newsletter.